120 related articles for article (PubMed ID: 17157908)
1. RNAi and tumor angiogenesis: bridging the gap towards anti-cancer therapy?
Dave RS
Leuk Res; 2007 Apr; 31(4):421-2. PubMed ID: 17157908
[No Abstract] [Full Text] [Related]
2. Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis.
Hadj-Slimane R; Lepelletier Y; Lopez N; Garbay C; Raynaud F
Biochimie; 2007 Oct; 89(10):1234-44. PubMed ID: 17707573
[TBL] [Abstract][Full Text] [Related]
3. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
4. RNA interference: generic block on angiogenesis.
Kalluri R; Kanasaki K
Nature; 2008 Apr; 452(7187):543-5. PubMed ID: 18385725
[No Abstract] [Full Text] [Related]
5. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
6. [Application of RNAi to cancer therapy].
Tan YL; Yin JQ
Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
[No Abstract] [Full Text] [Related]
7. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma.
Kim WJ; Christensen LV; Jo S; Yockman JW; Jeong JH; Kim YH; Kim SW
Mol Ther; 2006 Sep; 14(3):343-50. PubMed ID: 16765648
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesis.
Celec P; Yonemitsu Y
Biomed Pharmacother; 2008; 62(6):349-51. PubMed ID: 18406102
[TBL] [Abstract][Full Text] [Related]
9. Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth.
Liu T; Ye L; He Y; Chen X; Peng J; Zhang X; Yi H; Peng F; Leng A
Exp Mol Pathol; 2011 Dec; 91(3):745-52. PubMed ID: 21840308
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
11. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptide receptor a as a novel anticancer target.
Kong X; Wang X; Xu W; Behera S; Hellermann G; Kumar A; Lockey RF; Mohapatra S; Mohapatra SS
Cancer Res; 2008 Jan; 68(1):249-56. PubMed ID: 18172317
[TBL] [Abstract][Full Text] [Related]
14. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
[TBL] [Abstract][Full Text] [Related]
15. [RNAi and a gene therapy approach to diabetic retinopathies].
Kudo E; Shiota H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():302-5. PubMed ID: 15999724
[No Abstract] [Full Text] [Related]
16. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
Bulk E; Hascher A; Liersch R; Mesters RM; Diederichs S; Sargin B; Gerke V; Hotfilder M; Vormoor J; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2008 Mar; 68(6):1896-904. PubMed ID: 18339871
[TBL] [Abstract][Full Text] [Related]
17. Silence is golden: can RNA interference therapeutics deliver?
Beal J
Drug Discov Today; 2005 Feb; 10(3):169-72. PubMed ID: 15708529
[No Abstract] [Full Text] [Related]
18. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
19. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
20. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
